Next up.
Next-gen sequencing performed on blood samples from 24 patients on the day of their curative intent resection of oligometastatic colorectal cancer detected residual molecular disease with pretty perfect sensitivity and specificity and even revealed candidacy for immune checkpoint inhibition or targeted therapies. | Pellini, JCO Precis Oncol 2021
The method of execution is really impressive of writers of this blog. This team does really work hard and brings new information to its readers. I am connected with this blog very long and I am really thankful kubet lua dao
ReplyDelete